Institutional Profile: The Carolina Center of Cancer Nanotechnology Excellence: Past Accomplishments and Future Perspectives
Open accessAbstract
The Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) is funded by the National Cancer Institute and is based at the University of North Carolina. The C-CCNE features interactions between physical and biological scientists in a series of projects and cores that work together to quickly harness innovations in nanotechnology for the early diagnosis and treatment of cancer. Two key focus areas of the C-CCNE are, first, the selective delivery of drugs and imaging agents utilizing advanced nanoparticle technology, and second, novel approaches to imaging and radiotherapy utilizing carbon nanotube-based x-ray sources.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Intrastriatal implantation of silica-DA nanoformulation reversed symptoms in hemiparkinsonian rats with no observable side effects.
“Intrastriatal implantation of silica-DA nanoformulation also reversed the symptoms in hemiparkinsonian rats with no observable side effects.118”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918 · see citing works
Self-citationStationary scanning x-ray source based on carbon nanotube field emitters
Zhang, J., Yang, G., Cheng, Y., Gao, B., Qiu, Q., Lee, Y. Z., Lü, J., & Zhou, O. Z. (2005) · Applied Physics Letters · doi:10.1063/1.1923750 · Cited by 195 · see citing works
The Pursuit of a Scalable Nanofabrication Platform for Use in Material and Life Science Applications
Gratton, S. E. A., Williams, S., Napier, M. E., Pohlhaus, P. D., Zhou, Z., Wiles, K. B., Maynor, B. W., Shen, C. K.-F., Olafsen, T., Samulski, E. T., et al. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000348 · Cited by 142 · see citing works
Self-citationA dynamic micro-CT scanner based on a carbon nanotube field emission x-ray source
Cao, G., Lee, Y. Z., Peng, R., Liu, Z., Rajaram, R., Calderón‐Colón, X., An, L., Wang, P., Phan, T., Sultana, S., et al. (2009) · Physics in Medicine and Biology · doi:10.1088/0031-9155/54/8/005 · Cited by 124 · see citing works
The NCI Alliance for Nanotechnology in Cancer: achievement and path forward
Ptak, K., Farrell, D. F., Panaro, N. J., Grodzinski, P. A., & Barker, A. D. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.98 · Cited by 29 · see citing works
A Cancer Nanotechnology Strategy
Ferrari, M., Barker, A. D., & Downing, G. J. (2005) · Nanobiotechnology · doi:10.1385/nbt:1:2:129 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Sol–Gel Route to Advanced Silica-Based Materials and Recent Applications
Ciriminna, R., Fidalgo, A. M., Pandarus, V., Béland, F., Ilharco, L. M., & Pagliaro, M. (2013) · Chemical Reviews · doi:10.1021/cr300399c · Cited by 652 · see citing works
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works
Nonporous silica nanoparticles for nanomedicine application
Tang, L., & Cheng, J. (2013) · Nano Today · doi:10.1016/j.nantod.2013.04.007 · Cited by 489 · see citing works
Bullivant, J. P., Zhao, S., Willenberg, B. J., Kozissnik, B., Batich, C. D., & Dobson, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917501 · Cited by 117 · see citing works
Kim, H., Yang, S. M., Jang, T., Oh, N., Kim, H., & Hwang, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801071 · Cited by 72 · see citing works
Agnihotri, S., Pathak, R., Jha, D., Roy, I., Gautam, H. K., Sharma, A. K., & Kumar, P. (2015) · New Journal of Chemistry · doi:10.1039/c5nj00007f · Cited by 48 · see citing works
Chen, L., Tanner, E. E. L., Lin, C., & Compton, R. G. (2017) · Chemical Science · doi:10.1039/c7sc03672h · Cited by 39 · see citing works
MoS 2 nanohybrid as a fluorescence sensor for highly selective detection of dopamine
Mani, N. P., Ganiga, M., & Cyriac, J. (2018) · The Analyst · doi:10.1039/c7an01770g · Cited by 39 · see citing works
Llopis‐Lorente, A., Díez, P., de la Torre, C., Sánchez, A., Sancenón, F., Aznar, E., Marcos, M. D., Martínez‐Ruiz, P., Martínez‐Máñez, R., & Villalonga, R. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201700603 · Cited by 29 · see citing works
Nanomedicine to Overcome Current Parkinson’s Treatment Liabilities: A Systematic Review
Hawthorne, G. H., Bernuci, M. P., Bortolanza, M., Tumas, V., Issy, A. C., & Bel, E. A. D. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9663-z · Cited by 24 · see citing works
Catalano, P. N., Bourguignon, N. S., Álvarez, G. S., Libertun, C., Díaz, L. E., Desimone, M. F., & Lux-Lantos, V. A. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm30888f · Cited by 15 · see citing works
Eivazzadeh‐Keihan, R., Dogari, H., Ahmadpour, F., Aliabadi, H. A. M., Radinekiyan, F., Maleki, A. R., Fard, L. S., Tahmasebi, B., Mojdehi, M. F., & Mahdavi, M. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-92919-0 · Cited by 13 · see citing works
Colloidal suspensions of monodisperse diamond core-shells
Venerosy, A., Girard, H. A., Saada, S., Sennour, M., Stenger, I., Mermoux, M., & Arnault, J. (2018) · Diamond and Related Materials · doi:10.1016/j.diamond.2018.08.004 · Cited by 3 · see citing works
Sweet Fairytale: Carbohydrates as Backbones for Glyconanomedicine
Mizrahy, S., Landesman‐Milo, D., & Peer, D. (2013) · Israel Journal of Chemistry · doi:10.1002/ijch.201300068
- Authors
- Juliano, R. L., Sunnarborg, S., DeSimone, J., & Haroon, Z.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2010-12-23
- Volume
- 6
- Issue
- 1
- Pages
- 19-24
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- PMC
- PMC3712343
- OpenAlex
- W2161982411
- Cited by
- 14
- References
- 6
- Citations by year
- 2021: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 1 · 2013: 4 · 2012: 1
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nanomedicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p01gm059299-10)
- National Institute of General Medical Sciences (P01 GM-059299)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Engineering › Biomedical Engineering › Nanotechnology research and applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- cancer nanotechnology, nanoparticle drug delivery, carbon nanotube x-ray source, radiotherapy, early cancer detection, cancer therapy, interdisciplinary research center
- MeSH terms
- Academic Medical Centers, Humans, Neoplasms, North Carolina, Drug Delivery Systems, Nanotechnology, History, 21st Century, Nanomedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
